Clinical Guidelines for Acute Stroke Management - Living on the EDge

415 Saxena R, Koudstaal P. Anticoagulants versus
antiplatelet therapy <strong>for</strong> preventing stroke in patients with
nonrheumatic atrial fibrillation and a history of stroke or
transient ischemic attack. Cochrane Database of
Systematic Reviews 2004, Issue 4 Art No: CD000187
DOI: 101002/14651858CD000187pub2.
416 Hankey GJ. Role of lipid-modifying therapy in the
prevention of initial and recurrent stroke. Current
Opinion in Lipidology. 2002;13(6):645-51.
417 Amarenco P, Labreuche J, Lavallee P, Touboul PJ.
Statins in stroke prevention and carotid atherosclerosis:
Systematic review and up-to-date meta-analysis.
<strong>Stroke</strong>. 2004;35(12):2902-9.
418 Amarenco P, Bogousslavsky J, Callahan A, 3rd,
Goldstein LB, Hennerici M, Rudolph AE, et al. Highdose
atorvastatin after stroke or transient ischemic
attack (SPARCL). New England Journal of Medicine.
2006 Aug 10;355(6):549-59.
419 Cholesterol Treatment Trialists’ Collaboration. Efficacy
and safety of cholesterol-lowering treatment:
Prospective meta-analysis of data from 90 056
participants in 14 randomised trials of statins. Lancet.
2005;366(9493):1267-78.
420 Law M, Rudnicka AR. Statin Safety: A Systematic
Review. American Journal of Cardiology. 2006;97(8
SUPPL. 1):S52-S60.
421 De Denus S, Spinler SA, Miller K, Peterson AM. Statins
and Liver Toxicity: A Meta-Analysis. Pharmacotherapy.
2004;24(5 I):584-91.
422 Sanossian N, Saver JL, Liebeskind DS, Kim D, Razinia
T, Ovbiagele B. Achieving target cholesterol goals after
stroke: Is in-hospital statin initiation the key? Archives of
Neurology. 2006;63(8):1081-3.
423 Petty GW, Brown RD, Whisnant JP, Sicks JD, O'Fallon
WM, Wiebers DO. Survival and recurrence after first
cerebral infarction: a population-based study in
Rochester, Minnesota, 1975 through 1989. Neurology.
1998;50(1):208-16.
424 Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R,
Wolfe CD, et al. Cause of stroke recurrence is
multifactorial: patterns, risk factors, and outcomes of
stroke recurrence in the South London <strong>Stroke</strong> Register.
<strong>Stroke</strong>. 2003;34(6):1457-63.
425 Diabetes Australia Guideline Development Consortium.
National Evidence Based <strong>Guidelines</strong> <strong>for</strong> the
<strong>Management</strong> of Type 2 Diabetes Mellitus. Part 3 -
Evidence Based Guideline <strong>for</strong> Case Detection and
Diagnosis of Type 2 Diabetes. 2004.
426 Diabetes Australia Guideline Development Consortium.
National Evidence Based <strong>Guidelines</strong> <strong>for</strong> the
<strong>Management</strong> of Type 2 Diabetes Mellitus. Part 4 -
Guideline <strong>for</strong> Blood Pressure Control in Type 2 Diabetes.
2004.
427 Diabetes Australia Guideline Development Consortium.
National Evidence Based <strong>Guidelines</strong> <strong>for</strong> the
<strong>Management</strong> of Type 2 Diabetes Mellitus. Part 5 -
Guideline <strong>for</strong> the Prevention and Detection of
Macrovascular Disease in Type 2 Diabetes. 2004.
428 Diabetes Australia Guideline Development Consortium.
National Evidence Based <strong>Guidelines</strong> <strong>for</strong> the
<strong>Management</strong> of Type 2 Diabetes Mellitus. Part 7 -
Evidence Based Guideline <strong>for</strong> Lipid Control in Type 2
Diabetes. 2004.
429 Cina CS, Clase CM, Haynes RB. Carotid
endarterectomy <strong>for</strong> symptomatic carotid stenosis.
Cochrane Database of Systematic Reviews 1999, Issue
3. Art. No.: CD001081. DOI:
10.1002/14651858.CD001081.
430 Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor
DW, Mayberg MR, et al. Analysis of pooled data from
the randomised controlled trials of endarterectomy <strong>for</strong>
symptomatic carotid stenosis. Lancet. 2003 Jan
11;361(9352):107-16.
431 Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP,
Barnett HJM. Endarterectomy <strong>for</strong> symptomatic carotid
stenosis in relation to clinical subgroups and timing of
surgery. Lancet. 2004;363(9413):915-24.
432 Chambers BR, Donnan GA. Carotid endarterectomy <strong>for</strong>
asymptomatic carotid stenosis. Cochrane Database of
Systematic Reviews 2005, Issue 4. Art. No.:
CD001923. DOI: 10.1002/14651858.CD001923.pub2.
433 Rothwell PM, Slattery J, Warlow CP. A systematic
review of the risks of stroke and death due to
endarterectomy <strong>for</strong> symptomatic carotid stenosis.
<strong>Stroke</strong>. 1996;27(2):260-5.
434 Engelter S, Lyrer P. Antiplatelet therapy <strong>for</strong> preventing
stroke and other vascular events after carotid
endarterectomy. Cochrane Database of Systematic
Reviews 2003, Issue 3. Art. No.: CD001458. DOI:
10.1002/14651858.CD001458.
435 Payne DA, Jones CI, Hayes PD, Thompson MM,
London NJ, Bell PR, et al. Beneficial Effects of
Clopidogrel Combined with Aspirin in Reducing Cerebral
Emboli in Patients Undergoing Carotid Endarterectomy.
Circulation. 2004;109(12):1476-81.
436 Markus HS, Droste DW, Kaps M, Larrue V, Lees KR,
Siebler M, et al. Dual antiplatelet therapy with
clopidogrel and aspirin in symptomatic carotid stenosis
evaluated using doppler embolic signal detection: The
clopidogrel and aspirin <strong>for</strong> reduction of emboli in
symptomatic carotid stenosis (CARESS) trial.
Circulation. 2005;111(17):2233-40.
437 Coward LJ, Featherstone RL, Brown MM.
Percutaneous transluminal angioplasty and stenting <strong>for</strong>
carotid artery stenosis. Cochrane Database of
Systematic Reviews 2004, Issue 2. Art. No.:
CD000515. DOI: 10.1002/14651858.CD000515.pub2.
438 SPACE Trialists. 30 day results from the SPACE trial of
stent-protected angioplasty versus carotid
endarterectomy in symptomatic patients: a randomised
non-inferiority trial. Lancet. 2006;368(9543):1239-47.
439 Mas JL, Chatellier G, Beyssen B, Branchereau A,
Moulin T, Becquemin JP, et al. Endarterectomy versus
stenting in patients with symptomatic severe carotid
stenosis. New England Journal of Medicine.
2006;355(16):1660-71.
References
91